Nanoform Finland (OHEL:NANOFH) EV-to-EBIT : -6.52 (As of May. 25, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Nanoform Finland EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Nanoform Finland's Enterprise Value is €135.21 Mil. Nanoform Finland's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-20.73 Mil. Therefore, Nanoform Finland's EV-to-EBIT for today is -6.52.

The historical rank and industry rank for Nanoform Finland's EV-to-EBIT or its related term are showing as below:

OHEL:NANOFH' s EV-to-EBIT Range Over the Past 10 Years
Min: -31.77 Med: -9.09 Max: -3.07
Current: -6.52

During the past 8 years, the highest EV-to-EBIT of Nanoform Finland was -3.07. The lowest was -31.77. And the median was -9.09.

OHEL:NANOFH's EV-to-EBIT is ranked worse than
100% of 426 companies
in the Biotechnology industry
Industry Median: 10.295 vs OHEL:NANOFH: -6.52

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Nanoform Finland's Enterprise Value for the quarter that ended in Dec. 2023 was €82.69 Mil. Nanoform Finland's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-20.73 Mil. Nanoform Finland's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -25.06%.

Nanoform Finland EV-to-EBIT Historical Data

The historical data trend for Nanoform Finland's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanoform Finland EV-to-EBIT Chart

Nanoform Finland Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

-21.72

-21.37

-8.65

-3.99

Nanoform Finland Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															-8.65	-3.36	-5.16	-5.14	-3.99

Competitive Comparison of Nanoform Finland's EV-to-EBIT

For the Biotechnology subindustry, Nanoform Finland's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanoform Finland's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanoform Finland's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Nanoform Finland's EV-to-EBIT falls into.

Nanoform Finland EV-to-EBIT Calculation

Nanoform Finland's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	135.209	/	-20.726
	=	-6.52

Nanoform Finland's current Enterprise Value is €135.21 Mil.
Nanoform Finland's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-20.73 Mil.

Nanoform Finland (OHEL:NANOFH) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Nanoform Finland's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-20.726	/	82.68972
	=	-25.06 %

Nanoform Finland's Enterprise Value for the quarter that ended in Dec. 2023 was €82.69 Mil.
Nanoform Finland's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-20.73 Mil.

Nanoform Finland EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Nanoform Finland's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanoform Finland (OHEL:NANOFH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanoform Finland PLC (OHEL:NANOFH) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

NANOFS:Sweden 4YL:Germany

Address

Cultivator II, Viikinkaari 4, Helsinki, FIN, 00790

Website

https://www.nanoform.com

Nanoform Finland PLC is a nanoparticle medicine-enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nano-forming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nano-formed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceutical pipeline to progress into clinical development by increasing their rate of dissolution and by improving their bioavailability. Its technology provides novel opportunities in many value-enhancing drug delivery applications.

Nanoform Finland (OHEL:NANOFH) Headlines

No Headlines